An alliance of advocacy groups called The Partnership rallies Congress for funding while rejecting most Trump administration policies impacting the HIV community.
Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.
Given its anti-transgender policies and the lack of resources for trans health and survival, the administration may not be on track to end HIV by 2030.
We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.
Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.
Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.
The U.S.'s largest network of women living with HIV ramps up its strategy to develop more grassroots leaders -- and invites you to take action.
We have no reason to trust President Trump's State of the Union announcement on HIV -- and that's precisely why we should work with the administration anyway, Drew Gibson contends.
While some HIV advocates are hopeful about the announcement, some worry that other Trump policies negate any real prospects for positive change.
"For more than 30 months, transgender troops have been serving our country openly with valor and distinction, but now the rug has been ripped out from under them, once again," Lambda Legal Counsel Peter Renn said.